MoreLabs

MoreLabs sells science-backed dietary supplements and functional beverages aimed at recovery, focus, and liver support. Flagship SKUs include “Morning Recovery” hangover drink, “Liquid Focus” nootropic shot, and “Daily Detox” capsules, priced $4–$6 per single-serve bottle or $30–$45 for 12-packs and 30-day supplies—mid-range within the wellness category. Distribution is DTC through morelabs.com plus Amazon, and selective retail placements such as Whole Foods, CVS, and 7-Eleven. The brand positions itself as a biomedical R&D company rather than a lifestyle beverage maker; every formula is patented, double-blind–tested, and anchored on DHM (dihydromyricetin) for alcohol metabolism and nootropic stacks for cognitive performance. Their “Morning Recovery” has achieved viral status, reportedly selling 5 million bottles since 2017 and frequently topping Amazon’s hangover remedy sub-category. Core buyers are 21-35-year-old urban professionals who socialize frequently, travel for work, and want productivity without sacrificing nightlife; they value data over folklore and share lab-study screenshots on Reddit and TikTok. The messaging emphasizes “enjoy tonight, crush tomorrow,” aligning with bio-optimization, moderation-not-deprivation, and quantified-self cultures. MoreLabs competes against both legacy OTC hangover pills and emerging functional wellness shots; it differentiates by owning clinical IP, publishing peer-reviewed results, and using pharmaceutical-grade ingredients in beverage format for faster absorption. While competitors rely on herbal blends or electrolyte positioning, MoreLabs markets pharmacokinetic data and partners with universities to maintain a science-first moat.